ArticleAnnals of hematology2023

Real-life use of mTOR inhibitor-based therapy in adults with autoimmune cytopenia highlights strong efficacy in relapsing/refractory multi-lineage autoimmune cytopenia.

Boris Sorin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.